Y-Intercept (HK)’s Amedisys AMED Stock Holding History

Y-Intercept (HK)’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,475	Closed	-$834K	–	1539
2025 Q2	$834K	Buy	+8,475	New	+$802K	0.02%	1019
2023 Q2	–	Sell	-22,491	Closed	-$1.65M	–	1241
2023 Q1	$1.65M	Buy	22,491 +17,617	+361%	+$1.52M	0.19%	133
2022 Q4	$407K	Buy	+4,874	New	+$439K	0.06%	514
2022 Q3	–	Sell	-7,328	Closed	-$770K	–	942
2022 Q2	$770K	Buy	+7,328	New	+$936K	0.1%	290
2021 Q4	–	Sell	-12,770	Closed	-$1.9M	–	562
2021 Q3	$1.9M	Buy	12,770 +11,276	+755%	+$2.34M	0.35%	68
2021 Q2	$366K	Buy	1,494 +518	+53%	+$136K	0.09%	347
2021 Q1	$254K	Buy	+976	New	+$275K	0.07%	472

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Y-Intercept (HK)'s AMED Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Amedisys (AMED) in Q3 2025, closing a stake of 8,475 shares — an estimated $834K sold.

Y-Intercept (HK) first reported a position in AMED in Q1 2021 and held it in 7 quarters. The position peaked at $1.9M in Q3 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Y-Intercept (HK) reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 8,475 Amedisys shares in Q3 2025, an estimated $834K.
Y-Intercept (HK) first reported a position in Amedisys in Q1 2021 and held it in 7 quarters.
Y-Intercept (HK)'s Amedisys position peaked at $1.9M in Q3 2021.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.